Titan Pharmaceuticals Inc (TTNP) — Cash Flow Quality Index

Latest as of June 2016: 1.13x

Titan Pharmaceuticals Inc (TTNP) has a Cash Flow Quality Index of 1.13x as of June 2016. Operating cash flow of $13.51 Million exceeds net income of $11.93 Million, indicating high earnings quality where cash backs reported profits. Also explore balance sheet size of Titan Pharmaceuticals Inc for the complete picture of this company's asset base.

Cash Flow Quality Index

1.13x
Operating CF / Net Income

Operating Cash Flow

$13.51 Million
USD

Net Income

$11.93 Million
USD

Data as of

Jun 2016
Most recent filing

Titan Pharmaceuticals Inc Cash Flow Quality Index (1997–2016)

Historical Cash Flow Quality Index for Titan Pharmaceuticals Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Titan Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Titan Pharmaceuticals Inc (1997–2016)

Year-by-year earnings quality comparison for Titan Pharmaceuticals Inc. For live market cap and the full company financial profile, see Titan Pharmaceuticals Inc stock valuation.

Year Quality Index Operating CF (USD) Net Income YoY Change
2016 1.23x $6.29 Million $5.13 Million ▲ +221.5%
2013 -1.01x $-9.80 Million $9.71 Million ▼ -108.5%
1997 11.83x $7.10 Million $600.00K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.